JOIN THE BNMS             

               XLargeThumb.00006231-201401000-00000.CV

Twitter @BNMSnews

BNMS Achievements 2018

To all BNMS Members,

We want to thank you for your continued support.

Your membership has allowed us to achieve so much this year

In 2018 the BNMS has:

  • Kept members up-to-date on supply problems via the BNMS website and Wavelength newsletter.
  • Supported our members in applications for Clinical Excellence Awards
  • Embraced Social Media and have 1,175 and rising followers on Twitter
  • GDPR laws have come into force, contact has been made to all members and non-members informing them of the importance of the new law
  • We have appointed a developer for the new BNMS membership management system and website which we are currently working hard at to launch by the end of the year.
  • Joined the Academy for Healthcare Scientists as an observer member.
  • Established an excellent new rate for trainee members of the society including online access of NMC which will be launched with the new website.
  • Created a new RTNG Linkedin Group
  • We are working on developing a mentoring scheme as a means of supporting peoples’ careers and personal development.

Experienced professionals will be invited to become mentees and a training day will be provided for them.  Members will then be able to apply to the mentorship scheme for assistance in developing specific skills and knowledge to enhance their career and personal growth.  Details will be released in the coming months.

  • The Professional Standards Committee working with contacts at UKAS and the British Standards Institute to establish the way forward for accreditation in nuclear medicine.

BNMS has represented its members responding to consultations on issues affecting the specialty EURATOM and Brexit

  • The BNMS has actively responded to statements on leaving EURATOM, issuing press releases and being quoted in the media and the press on the impact of leaving EURATOM on patient services.
  • Liaising with the department of health, the Health Select Committee enquiry into Brexit, the House of Commons and EURATOM.
  • Attended the Medical radioisotope stakeholder meeting (Department of Health)
  • The BNMS President made a visit to the Hong Kong Society of Nuclear Medicine
  • Advising nuclear medicine departments on nuclear medicine in the risk register
  • Raised concerns about the issues of access to Lutathera for patients in certain areas of England where there are no ARSAC license holders with a letter to Mr Grahame Morris MP
  • Submitted a comprehensive report on the possible effects of a ‘No Deal’ Brexit on nuclear medicine services to the House of Commons.
  • BNMS has been quoted in the press here: In the Times, The Financial Times, The Guardian and The Mail on Sunday with multiple interviews for BBC Radio
  • Representation at the OECD observatory meeting on radioisotope supply

Publications

  • We have published additional books in the PET-CT Pocket Books Series: Clinicians’ Guides to PET/CT in Thyroid Cancer, PET/CT in Colorectal Cancer, PET/CT in Gynecological Cancers, PET/CT in Head and Neck Cancer, PET/CT in Hepatobiliary and Pancreatic Malignancies, PET/CT in Hodgkin’s Lymphoma, PET/CT in Lung Cancer, PET/CT in Neuroendocrine Tumours, PET/CT in Oesophageal and Gastric Cancer and PET/CT in Radiotherapy Planning
  • Published the BNMS Clinical Guideline for Lacrimal Scintigraphy and the Clinical Guidelines for the measurement of glomerular filtration rate (GFR) using plasma sampling

Meetings:

  • Held two successful scientific meetings with excellent feedback from delegates on their content and usefulness.
  • BNMS 46th Annual Spring Meeting, Birmingham April 2018
  • Joint BNMS/INMA Autumn Meeting 2018, Dublin November 2018
  • Held a successful BNMS session at the SNMMI annual meeting in Philadelphia.
  • Represented the Society at the EANM 2018 meeting in Dusseldorf in order to keep up to date with current developments and to network with Nuclear Medicine colleagues from elsewhere in Europe.
  • Represented the Society at the Medical Imaging Convention at the London Excel

In addition we have:

  • supported the following meetings with endorsement, CPD application and/or financial management assistance:

Midlands Regional Meeting, National Space Centre 12 June 2018

North Thames Regional Meeting, UCLH 6 September 2018

Second annual Radiographers & Technologist Nuclear Medicine update, Royal Free Hospital London 14 September 2018

East Anglia Nuclear Medicine Meeting, Suffolk Food Hall Ipswich 3 October 2018

GFR Masterclass, Royal Free Hospital, London 7 November 2018

Stress Leaders Course, Glasgow Royal Infirmary 26 November 2018

Lung Imaging Biomarkers Course, University College London 10 December 2018

Consultations

  • Responded to consultations on IRMER.
  • Responded to an AHCS consultation on their workforce document highlighting workforce issues.
  • Contributed to guideline development with NICE, topics include: 
  • Draft guideline on Oesophago-gastric cancer
  • Thyroid disease
  • Early and locally advanced breast cancer (update) 
  • Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinoma IP1081/2
  • SIRT in the treatment of chemotherapy refractory and intolerant, unresectable metastatic colorectal cancer (adults)

Surveys

  • Collected valuable workforce data by launching the fifth wave of the BNMS Workforce Survey.
  • Surveyed departments on radioiodine treatments of benign thyroid disease
  • Engaged with an EU wide survey, circulating to UK departments focusing on Mo-99 mandated by the European Commission

Awards

  • Launched a new Award “Lee Jenkins Memorial Prize Poster Prize”, honouring and remembering Lee Jenkins who passed away in 2017.
  • Awards were also presented as follows:

President's Medal, Prof Jamshed Bomanji, University College London Hospital

BNMS Roll of Honour, Prof Valerie Lewington, Guy's and St Thomas' Hospital and Prof Wim Oyen, The Royal Marsden NHS Foundation Trust

Norman Veall Medal, Mr Roger Staff, Aberdeen Royal Infirmary

Radiographers, Technologists & Nurses Group Award, Mr Neil Smith, formerly of City Hospital Birmingham

Ros Breen Award, Ellie Knowler, University Hospital of Wales Cardiff

  • Prepared for the launch of the BNMS Fellowships in Radionuclide Imaging and Therapy – inviting departments, who have the appropriate infrastructure and trainers in diagnostic and therapeutic nuclear medicine to host trainees.
  • Launched the BNMS Innovative Team of the Year Award

International and National Representation

BNMS representatives’ also sit on the following committees:

High-Level Group on the Security of Supply of Medical Radioisotopes (HLG-MR)

World Federation of Nuclear Medicine and Biology meetings in Melbourne and Dusseldorf.

BIR Nuclear Medicine and Molecular Imaging Committee

Environment Agency Small User liaison Group

EANM Delegates Assembly

RCP Intercollegiate Standing Committee on Nuclear Medicine

IPEM Nuclear Medicine Special Interest Group

Joint Royal Colleges of Physicians Training Board Specialist Advisory Committee in Nuclear Medicine

NHSE Cancer Diagnosis Clinical Reference Group

JRCPTB Specialist Advisory Committee

Society for Radiological Protection

Royal College of Physicians Expert Advisory Group on Commissioning

European Association of Nuclear Medicine Task Force on New Clinical Trial Regulation Section of Nuclear Medicine of the European Union of Medical Specialists and European Board of Nuclear Medicine

World Federation of Nuclear Medicine and Biology

Health Research Authority Radiation Working Group

National Institute for Health Research Clinical Reference Steering Group

British Thoracic Society Quality Standards Group

National School of Healthcare Science Physical Sciences Themed Board

Formal visits of the President of the BNMS to

Society of Nuclear Medicine, India

Pakistan Society of Nuclear Medicine

South African Society of Nuclear Medicine

 

Without the support of our members and dedicated volunteers we wouldn't have been able to accomplish all that we have.

Thank you once again for all your support, dedication and enthusiasm for maintaining the voice and profile of nuclear medicine in the UK and abroad.